AI could eliminate biopsies, change diagnosis of thyroid nodules -- top stories in endocrinology

The top stories in endocrinology last week focused on how artificial intelligence, or AI, could be a game-changer in predicting nonalcoholic fatty liver disease and detecting thyroid nodules. AI tool for nonalcoholic fatty liver disease could'make biopsies history' The detection and diagnosis of thyroid nodules may be on the cusp of a technological overhaul as a growing body of research on AI and machine learning tools aims to bring about more efficiency and accuracy while decreasing cost and improving ease-of-use. The Dermatologic and Ophthalmic Drugs Advisory Committee of the FDA voted 12-0 last week in favor of recommending approval of a biologics license application for teprotumumab, an experimental human monoclonal antibody shown to dramatically reduce the most debilitating symptoms of Graves' orbitopathy. The Society for Endocrinology and the British Thyroid Association issued a joint statement urging caution when interpreting a recent study linking radioactive iodine therapy to cancer mortality among people with hyperthyroidism. Japanese adults with type 2 diabetes assigned a long-term low-dose aspirin regimen did not lower their risk for dementia vs. similar adults who did not routinely take aspirin, according to a post hoc analysis of the Japanese Primary Prevention of Atherosclerosis with Aspirin for Diabetes trial.